US FDA approves Gilead's twice-yearly injection for HIV prevention
Go back to US FDA approves Gilead's twice-yearly injection for HIV prevention| Gilead Sciences (NASDAQ: GILD) | Delayed: 146.79 +3.35 (2.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $143.44 | 52 Week High | $108.63 | |||
| Open | $144.52 | 52 Week Low | $71.39 | |||
| Day High | $147.91 | P/E | 81.10 | |||
| Day Low | $143.50 | EPS | $1.81 | |||
| Volume | 2,174,773 | |||||
